April 17, 2019
- Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report (HTML)
- Low-dose Anti-Thymocyte Globulin Preserves C-Peptide and Reduces A1c in New Onset Type 1 Diabetes: Two Year Clinical Trial Data (HTML)
- Human beta cells generated from pluripotent stem cells or cellular reprogramming for curing diabetes
- Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy
- Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management
- Identifying Pathogenic Variants of Monogenic Diabetes Using Targeted Panel Sequencing in an East Asian Population (HTML)
- The Role of Type I Diabetes in Intervertebral Disc Degeneration (HTML)
- Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes (HTML)
- Diabetes-Related Complications and Mortality in Patients With Young-Onset Latent Autoimmune Diabetes: A 14-Year Analysis of the Prospective Hong Kong Diabetes Register (HTML)
- Variants in the BACH2 and CLEC16A gene may be associated with susceptibility to insulin-triggered type 1 diabetes (HTML | PDF)
- Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials (HTML)
- Neurological Alterations in Type 1 Diabetes Mellitus Among Adolescents (HTML)
- Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus (HTML)
- Adeno-associated virus neutralising antibodies in type 1 diabetes mellitus (HTML)
